Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $97.17 ($600K) on 2016-09-14, disclosed to the SEC on 2016-09-16.
Scheduled sale ($600k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.76 | 400 | $36K | 5.9% |
| 2 | $89.80 | 3,500 | $314K | 52.3% |
| 3 | $90.27 | 200 | $18K | 3.0% |
| 4 | $96.20 | 700 | $67K | 11.2% |
| 5 | $97.17 | 1,700 | $165K | 27.5% |
| Total | $92.37 avg | 6,500 |
| $600K |
| 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |